help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cockburn, B. N.
Right arrow Articles by Bell, G. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cockburn, B. N.
Right arrow Articles by Bell, G. I.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 2 971-978
Copyright © 2004 by The Endocrine Society

Insulin Promoter Factor-1 Mutations and Diabetes in Trinidad: Identification of a Novel Diabetes-Associated Mutation (E224K) in an Indo-Trinidadian Family

Brian N. Cockburn, Giovanna Bermano, Laura-Lee G. Boodram, Surujpal Teelucksingh, Takafumi Tsuchiya, Deepak Mahabir, Andrew B. Allan, Roland Stein, Kevin Docherty and Graeme I. Bell

Department of Life Sciences (B.N.C., L.G.B.), Faculty of Science and Agriculture, University of the West Indies, St. Augustine, Republic of Trinidad and Tobago; Department of Molecular and Cell Biology (G.B., A.B.A., K.D.), University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen, AB25 2ZD, United Kingdom; Department of Biochemistry and Molecular Biology (B.N.C., L.G.B., T.T., G.I.B.), The University of Chicago, Chicago, Illinois 60637; Department of Clinical Medical Sciences (S.T.), Faculty of Medical Sciences, University of the West Indies, St. Augustine, Republic of Trinidad and Tobago; Nutrition and Metabolism Unit (D.M.), Ministry of Health, Republic of Trinidad and Tobago; and Department of Molecular Physiology and Biophysics (R.S.), Vanderbilt University Medical School, Nashville, Tennessee 37232

Address all correspondence and requests for reprints to: B. N. Cockburn, Ph.D., Department of Life Sciences, Faculty of Science and Agriculture, University of the West Indies, St. Augustine, Republic of Trinidad and Tobago. E-mail: bcockburn{at}fans.uwi.tt.

This study investigated the prevalence of insulin promoter factor-1(IPF-1) mutations in familial early-onset diabetes mellitus in Trinidad. We screened 264 unrelated subjects with type 2 diabetes diagnosed before 40 yr of age and a family history of diabetes for mutations in the minimal promoter and coding region of the IPF-1 gene (IPF1). This study population included 169 patients of East Indian descent (Indo-Trinidadians), 66 of African descent (Afro-Trinidadians), and 29 of mixed ancestry. We identified five IPF1 variants, including one new missense mutation E224K, the previously described diabetes-associated duplication P242 P243dupP, two silent mutations in the codons for Leu54 (c.162G>A) and Ala256 (c.768C>A), and a substitution in the 5'-untranslated region (c.-18C>T). The E224K mutation was found in two unrelated diabetic Indo-Trinidadians and 0 of 60 controls. It was present on the same haplotype in both patients suggesting a founder effect. The E224K mutation cosegregated with early-onset diabetes or impaired glucose tolerance in a large family, suggestive of the type 4 form of maturity-onset diabetes of the young rather than type 2 diabetes. Functional studies of E224K showed reduced transactivation activity. IPF1 mutations leading to synthesis of a mutant protein may contribute to the development of familial early-onset diabetes/maturity-onset diabetes of the young in Indo-Trinidadians.

This work was supported by grants from the University of the West Indies Research and Publications Fund, the U.S. Public Health Service (DK-20595, DK-50203, and DK-44840), and the Wellcome Trust. G.I.B. is an Investigator of the Howard Hughes Medical Institute.

Abbreviations: CAT, Chloramphenicol acetyl transferase; HOMA-R, homeostatic model assessment insulin resistance; IGT, impaired glucose tolerance; IPF-1, insulin promoter factor-1; MODY, maturity-onset diabetes of the young; OGTT, oral glucose tolerance testing; PDX-1, pancreatic duodenal homeobox-1; SV, simian virus; TK, thymidine kinase; WT, wild-type.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M.-J. Boucher, L. Selander, L. Carlsson, and H. Edlund
Phosphorylation Marks IPF1/PDX1 Protein for Degradation by Glycogen Synthase Kinase 3-dependent Mechanisms
J. Biol. Chem., March 10, 2006; 281(10): 6395 - 6403.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society